全文获取类型
收费全文 | 22844篇 |
免费 | 2189篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 196篇 |
儿科学 | 888篇 |
妇产科学 | 501篇 |
基础医学 | 2943篇 |
口腔科学 | 477篇 |
临床医学 | 2616篇 |
内科学 | 4700篇 |
皮肤病学 | 178篇 |
神经病学 | 2139篇 |
特种医学 | 998篇 |
外科学 | 3147篇 |
综合类 | 407篇 |
一般理论 | 12篇 |
预防医学 | 2458篇 |
眼科学 | 465篇 |
药学 | 1540篇 |
中国医学 | 31篇 |
肿瘤学 | 1387篇 |
出版年
2021年 | 349篇 |
2020年 | 208篇 |
2019年 | 400篇 |
2018年 | 411篇 |
2017年 | 271篇 |
2016年 | 336篇 |
2015年 | 360篇 |
2014年 | 601篇 |
2013年 | 890篇 |
2012年 | 1220篇 |
2011年 | 1237篇 |
2010年 | 710篇 |
2009年 | 654篇 |
2008年 | 1150篇 |
2007年 | 1227篇 |
2006年 | 1152篇 |
2005年 | 1117篇 |
2004年 | 1094篇 |
2003年 | 1079篇 |
2002年 | 1067篇 |
2001年 | 498篇 |
2000年 | 515篇 |
1999年 | 460篇 |
1998年 | 312篇 |
1997年 | 272篇 |
1996年 | 296篇 |
1995年 | 276篇 |
1994年 | 263篇 |
1993年 | 261篇 |
1992年 | 382篇 |
1991年 | 310篇 |
1990年 | 347篇 |
1989年 | 372篇 |
1988年 | 304篇 |
1987年 | 317篇 |
1986年 | 340篇 |
1985年 | 299篇 |
1984年 | 267篇 |
1983年 | 247篇 |
1982年 | 207篇 |
1981年 | 211篇 |
1980年 | 161篇 |
1979年 | 218篇 |
1978年 | 189篇 |
1977年 | 138篇 |
1976年 | 158篇 |
1975年 | 153篇 |
1974年 | 148篇 |
1973年 | 146篇 |
1972年 | 126篇 |
排序方式: 共有10000条查询结果,搜索用时 334 毫秒
11.
12.
Thomas R. Russell 《American journal of surgery》2009,197(6):826-827
In recent years, the surgical profession has attempted to incorporate into clinical practice certain techniques that the airline industry has used to improve safety. These mechanisms have proven to be valuable components of our efforts to ensure that surgical patients receive safe, high-quality care. However, as the authors of “Cost and workforce implications of subjecting all physicians to aviation industry work hour restrictions” note, it would be a mistake to extend aviation's work-hour restrictions to medicine, particularly to resident training programs. 相似文献
13.
14.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
15.
We have compared the effects of acetyl salicylic acid (ASA, aspirin) and choline magnesium trisalicylate (CMT), a non-acetylated salicylate product, on platelet aggregation in human whole blood ex-vivo. Using a whole blood platelet counter, platelet aggregation was quantified by measuring the fall in the number of single platelets at peak aggregation in response to collagen, arachidonic acid (AA), as well as spontaneous aggregation. In double blind and random order, 12 healthy volunteers received, on two separate occasions 10 days apart, a single oral dose of 652 mg ASA or 655 mg CMT. Despite a comparable absorption of salicylic acid from the two drugs, ingestion of ASA resulted in a marked inhibition of platelet aggregation induced by collagen (p less than 0.005), AA (p less than 0.01) and spontaneous aggregation (p less than 0.01), whereas such effects were not observed after CMT ingestion. We suggest that CMT may have therapeutic potential as an alternative to aspirin when inhibition of platelet aggregation can induce bleeding complications. 相似文献
16.
Russell L. Deter 《Journal of clinical ultrasound : JCU》1986,14(6):420-420
17.
18.
Sir Alexander J. H. Russell 《Indian medical gazette》1939,74(3):164-167
19.
20.